Chemotherapeutic Treatments Increase PD-L1 Expression in Esophageal Squamous Cell Carcinoma through EGFR/ERK Activation

The current study reveals the clinicopathological association of PD-L1 in Hong Kong esophageal squamous cell carcinoma (ESCC) patients and the differential regulation of PD-L1 by standard first-line chemotherapy in ESCC. Immunohistochemical analysis of tissue microarray data from 84 Hong Kong ESCC p...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Transl Oncol
Autors principals: Ng, Hoi Yan, Li, Jian, Tao, Lihua, Lam, Alfred King-Yin, Chan, Kwok Wah, Ko, Josephine Mun Yee, Yu, Valen Zhuoyou, Wong, Michael, Li, Benjamin, Lung, Maria Li
Format: Artigo
Idioma:Inglês
Publicat: Neoplasia Press 2018
Matèries:
Original article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6122398/
https://ncbi.nlm.nih.gov/pubmed/30172884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2018.08.005
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars